Surgery Partners, Inc. (SGRY) stock
SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/3011% above fair value
$26.96+0.11 (+0.41%)
Close on Nov 18, 2026Market cap $3.53BP/E –Yield –
Surgery Partners revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Surgery Partners's revenue for the twelve months ending Jun 30, 2026 was $3.37B, up 4.0% year over year. For fiscal 2025 it was $3.31B, up 6.2% from the year before. Over ten years it grew 23.4% a year on average. The highest annual figure on record is $3.31B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.31B | +6.2% |
| FY2024 | Dec 31, 2024 | $3.11B | +13.5% |
| FY2023 | Dec 31, 2023 | $2.74B | +8.0% |
| FY2022 | Dec 31, 2022 | $2.54B | +14.1% |
| FY2021 | Dec 31, 2021 | $2.23B | +19.6% |
| FY2020 | Dec 31, 2020 | $1.86B | +1.6% |
| FY2019 | Dec 31, 2019 | $1.83B | +3.4% |
| FY2018 | Dec 31, 2018 | $1.77B | +54.7% |
| FY2016 | Dec 31, 2016 | $1.15B | +19.3% |
| FY2015 | Dec 31, 2015 | $959.89M | +138.0% |
| FY2014 | Dec 31, 2014 | $403.29M | +41.7% |
| FY2013 | Dec 31, 2013 | $284.60M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $848.90M | +2.7% |
| Q1 FY2026 | Mar 31, 2026 | $810.90M | +4.5% |
| Q4 FY2025 | Dec 31, 2025 | $885.00M | +2.4% |
| Q3 FY2025 | Sep 30, 2025 | $821.50M | +6.6% |
| Q2 FY2025 | Jun 30, 2025 | $826.20M | +8.4% |
| Q1 FY2025 | Mar 31, 2025 | $776.00M | +8.2% |
| Q4 FY2024 | Dec 31, 2024 | $864.40M | +17.5% |
| Q3 FY2024 | Sep 30, 2024 | $770.40M | +14.3% |
| Q2 FY2024 | Jun 30, 2024 | $762.10M | +14.2% |
| Q1 FY2024 | Mar 31, 2024 | $717.40M | +7.7% |
| Q4 FY2023 | Dec 31, 2023 | $735.40M | +4.0% |
| Q3 FY2023 | Sep 30, 2023 | $674.10M | +8.6% |
| Q2 FY2023 | Jun 30, 2023 | $667.60M | +8.5% |
| Q1 FY2023 | Mar 31, 2023 | $666.20M | +11.7% |
| Q4 FY2022 | Dec 31, 2022 | $707.10M | +15.9% |
| Q3 FY2022 | Sep 30, 2022 | $620.60M | +11.0% |
| Q2 FY2022 | Jun 30, 2022 | $615.40M | +13.3% |
| Q1 FY2022 | Mar 31, 2022 | $596.20M | +16.4% |
| Q4 FY2021 | Dec 31, 2021 | $610.20M | +11.3% |
| Q3 FY2021 | Sep 30, 2021 | $559.20M | +12.7% |
| Q2 FY2021 | Jun 30, 2021 | $543.30M | +45.0% |
| Q1 FY2021 | Mar 31, 2021 | $512.40M | +16.2% |
| Q4 FY2020 | Dec 31, 2020 | $548.30M | +6.0% |
| Q3 FY2020 | Sep 30, 2020 | $496.10M | +9.8% |
| Q2 FY2020 | Jun 30, 2020 | $374.70M | -15.9% |
| Q1 FY2020 | Mar 31, 2020 | $441.00M | +5.8% |
| Q4 FY2019 | Dec 31, 2019 | $517.20M | +5.3% |
| Q3 FY2019 | Sep 30, 2019 | $452.00M | +4.5% |
| Q2 FY2019 | Jun 30, 2019 | $445.40M | +2.0% |
| Q1 FY2019 | Mar 31, 2019 | $416.80M | +1.3% |
| Q4 FY2018 | Dec 31, 2018 | $491.20M | +6.7% |
| Q3 FY2018 | Sep 30, 2018 | $432.40M | +50.0% |
| Q2 FY2018 | Jun 30, 2018 | $436.60M | +52.6% |
| Q1 FY2018 | Mar 31, 2018 | $411.30M | +34.4% |
| Q4 FY2017 | Dec 31, 2017 | $460.35M | +62.8% |
| Q2 FY2017 | Jun 30, 2017 | $288.35M | – |
| Q1 FY2017 | Mar 31, 2017 | $286.18M | – |
| Q4 FY2016 | Dec 31, 2016 | $306.00M | – |
| Q3 FY2016 | Sep 30, 2016 | $282.68M | – |
See a number that looks wrong?